(NP (NP (NN T) (NN cell) (NN response)) (PP (TO to) (NP (JJ Epstein-Barr) (NN virus) (NNS transactivators))) (PP (IN in) (NP (JJ chronic) (JJ rheumatoid) (NN arthritis))) (. .))
(S (NP-SBJ (JJ Rheumatoid) (NN arthritis)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ multistep) (NN disorder)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NP (JJ autoimmune) (NNS features)) (PP (IN of) (NP (ADJP (RB yet) (JJ unknown)) (NN etiology)))))))) (. .))
(S-COOD (S (NP-SBJ-71 (NP (NN Implication)) (PP (IN of) (NP (NP (NNS viruses)) (PP (JJ such) (IN as) (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-)))))) (PP (IN in) (NP (JJ rheumatoid) (NN arthritis) (NN pathogenesis)))) (VP (VBZ has) (VP (VBN been) (VP (VBN suspected) (NP (-NONE- *-71)) (PP (IN on) (DT the) (NN basis) (IN of) (NP (JJ several) (JJ indirect) (NNS observations))))))) (, ,) (CC but) (S (ADVP-TMP (RB thus) (RB far)) (, ,) (NP-SBJ-72 (NP (DT a) (JJ direct) (NN link)) (PP (IN between) (NP-COOD (NP (NN EBV)) (CC and) (NP (JJ rheumatoid) (NN arthritis))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN provided) (NP (-NONE- *-72)))))) (. .))
(S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ large) (NN fraction)) (PP (IN of) (NP (NN T) (NNS cells))) (VP (VBG infiltrating) (NP (NP (VBN affected) (NNS joints)) (PP (IN from) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ chronic) (JJ rheumatoid) (NN arthritis)))))))) (VP (VBZ recognizes) (NP (NP (CD two) (NN EBV) (NNS transactivators)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN BZLF1)) (CC and) (NP (NN BMLF1))) (-RRB- -RRB-))) (PP (IN in) (NP (DT a) (ADJP (JJ major) (NN histocompatibility) (JJ complex-restricted)) (NN fashion))))))) (. .))
(S (NP-SBJ (NP (NNS Responses)) (PP (TO to) (NP (DT these) (NN EBV) (NNS antigens))) (PP (IN by) (NP (NP (JJ synovial) (NNS lymphocytes)) (PP (IN from) (NP (JJ several) (JJ other) (JJ chronic) (JJ rheumatoid) (NN arthritis) (NNS patients)))))) (VP (VBD were) (ADJP-PRD (RB readily) (JJ detectable))) (. .))
(S (ADVP (RB Thus)) (NP-SBJ (DT these) (NNS results)) (VP (VBP suggest) (NP (NP (DT a) (JJ direct) (NN contribution)) (PP (IN of) (NP (NN EBV))) (PP (TO to) (NP (JJ chronic) (JJ rheumatoid) (NN arthritis) (NN pathogenesis))))) (. .))
(S (NP-SBJ (PRP They)) (ADVP (RB also)) (VP (VBP demonstrate) (PP-TMP (IN for) (NP (DT the) (JJ first) (NN time))) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NN T) (NN cell) (NNS responses)) (PP (IN against) (NP (NN EBV) (VBG transactivating) (NNS factors))))) (, ,) (SBAR (WHNP-73 (WDT which)) (S (NP-SBJ (-NONE- *T*-73)) (VP (MD might) (VP (VB be) (ADJP-PRD (JJ central)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NN virus) (NN reactivation))))))))))) (. .))
